Arvest Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $8.1M | Sell |
118,075
-4,749
| -4% | -$326K | 0.48% | 57 |
|
|
2024
Q1 | $9M | Sell |
122,824
-3,234
| -3% | -$237K | 0.51% | 55 |
|
|
2023
Q4 | $10.2M | Sell |
126,058
-2,961
| -2% | -$240K | 0.62% | 51 |
|
|
2023
Q3 | $9.67M | Sell |
129,019
-810
| -0.6% | -$60.7K | 0.63% | 52 |
|
|
2023
Q2 | $9.89M | Sell |
129,829
-3,875
| -3% | -$295K | 0.59% | 52 |
|
|
2023
Q1 | $11.1M | Sell |
133,704
-6,391
| -5% | -$530K | 0.69% | 47 |
|
|
2022
Q4 | $12M | Sell |
140,095
-14,052
| -9% | -$1.21M | 0.76% | 46 |
|
|
2022
Q3 | $9.51M | Sell |
154,147
-5,141
| -3% | -$317K | 0.65% | 49 |
|
|
2022
Q2 | $9.85M | Sell |
159,288
-1,235
| -0.8% | -$76.3K | 0.64% | 49 |
|
|
2022
Q1 | $9.54M | Sell |
160,523
-3,292
| -2% | -$196K | 0.53% | 54 |
|
|
2021
Q4 | $11.9M | Buy |
+163,815
| New | +$11.9M | 0.63% | 50 |
|
|
2014
Q2 | $18.6M | Buy |
224,080
+703
| +0.3% | +$58.3K | 1.72% | 12 |
|
|
2014
Q1 | $17.5M | Sell |
223,377
-1,779
| -0.8% | -$140K | 1.69% | 13 |
|
|
2013
Q4 | $16.9M | Sell |
225,156
-5,370
| -2% | -$403K | 1.68% | 16 |
|
|
2013
Q3 | $14.5M | Sell |
230,526
-230,447
| -50% | -$14.5M | 1.58% | 21 |
|
|
2013
Q2 | $23.6M | Buy |
+460,973
| New | +$23.6M | 2.71% | 7 |
|